Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Front Aging ; 4: 1270838, 2023.
Article in English | MEDLINE | ID: mdl-37840813

ABSTRACT

Since its initial discovery almost three decades ago, the transcription factor nuclear factor erythroid 2-related factor 2 (NRF2) has been shown to regulate a host of downstream transcriptional responses and play a critical role in preventing or promoting disease progression depending on the context. Critically, while the importance of proper nuclear factor erythroid 2-related factor 2 function has been demonstrated across a variety of pathological settings, the ability to progress NRF2-targeted therapeutics to clinic has remained frustratingly elusive. This is particularly true in the case of age-related pathologies, where nuclear factor erythroid 2-related factor 2 is a well-established mitigator of many of the observed pathogenic effects, yet options to target this pathway remain limited. Along these lines, loss of nuclear factor erythroid 2-related factor 2 function has clearly been shown to enhance neuropathological outcomes, with enhancing nuclear factor erythroid 2-related factor 2 pathway activation to prevent neurodegenerative/neurological disease progression continuing to be an active area of interest. One critical obstacle in generating successful therapeutics for brain-related pathologies is the ability of the compound to cross the blood brain barrier (BBB), which has also hampered the implementation of several promising nuclear factor erythroid 2-related factor 2 inducers. Another limitation is that many nuclear factor erythroid 2-related factor 2 activators have undesirable off-target effects due to their electrophilic nature. Despite these constraints, the field has continued to evolve, and several viable means of targeting nuclear factor erythroid 2-related factor 2 in a neuropathological context have emerged. In this perspective, we will briefly discuss the key findings and promising therapeutic options that have been discovered to date, as well as highlight emerging areas of NRF2-neurodegeneration research that provide hope for successfully targeting this pathway in the future.

2.
Front Plant Sci ; 7: 392, 2016.
Article in English | MEDLINE | ID: mdl-27066040

ABSTRACT

In plant factories, plants are usually cultivated in nutrient solution under a controllable environment. Plant quality and growth are closely monitored and precisely controlled. For plant growth evaluation, plant weight is an important and commonly used indicator. Traditional plant weight measurements are destructive and laborious. In order to measure and record the plant weight during plant growth, an automated measurement system was designed and developed herein. The weight measurement system comprises a weight measurement device and an imaging system. The weight measurement device consists of a top disk, a bottom disk, a plant holder and a load cell. The load cell with a resolution of 0.1 g converts the plant weight on the plant holder disk to an analog electrical signal for a precise measurement. The top disk and bottom disk are designed to be durable for different plant sizes, so plant weight can be measured continuously throughout the whole growth period, without hindering plant growth. The results show that plant weights measured by the weight measurement device are highly correlated with the weights estimated by the stereo-vision imaging system; hence, plant weight can be measured by either method. The weight growth of selected vegetables growing in the National Taiwan University plant factory were monitored and measured using our automated plant growth weight measurement system. The experimental results demonstrate the functionality, stability and durability of this system. The information gathered by this weight system can be valuable and beneficial for hydroponic plants monitoring research and agricultural research applications.

SELECTION OF CITATIONS
SEARCH DETAIL
...